(Q37724259)

22 August 2017

1 reference

title

The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer (English)

1 reference

22 August 2017

1 reference

1 reference

1

Cesare Gridelli

1 reference

22 August 2017

Antonio Rossi

2

1 reference

22 August 2017

Maria Anna Bareschino

3

1 reference

22 August 2017

Clorinda Schettino

4

1 reference

22 August 2017

Paola Claudia Sacco

5

1 reference

22 August 2017

Paolo Maione

6

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Expert Opinion on Investigational Drugs

22 August 2017

published in

1 reference

22 August 2017

volume

19

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

631-639

1 reference

22 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Biological prognostic and predictive factors in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Molecular interactions of the IGF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

IGF2: epigenetic regulation and role in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

The insulin-like growth factor system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Structure and functional analysis of the IGF-II/IGF2R interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Targeting insulin-like growth factor pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Motility response to insulin-like growth factor-I (IGF-I) in MCF-7 cells is associated with IRS-2 activation and integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Molecular and cellular aspects of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Regulation of neuronal survival by the serine-threonine protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Advances in protein kinase B signalling: AKTion on multiple fronts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Structure and autoregulation of the insulin-like growth factor 1 receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

IMC-A12, a human IgG1 monoclonal antibody to the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

A fully human insulin-like growth factor-I receptor antibody SCH 717454 (Robatumumab) has antitumor activity as a single agent and in combination with cytotoxics in pediatric tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

The insulin-like growth factor pathway in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543781003767434

10.1517/13543781003767434

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference